Blood Test to Check Hepatitis B Immunity from Vaccine
The blood test to determine immunity after hepatitis B vaccination is anti-HBs (antibody to hepatitis B surface antigen), measured using a quantitative assay that can detect levels ≥10 mIU/mL. 1
Specific Test and Timing
- Order a quantitative anti-HBs test using a method such as ELISA that reliably detects the protective threshold of ≥10 mIU/mL 1, 2
- Optimal timing is 1–2 months after the final vaccine dose to capture peak antibody response before natural decline begins 1, 2
- Anti-HBs ≥10 mIU/mL defines protective immunity and successful vaccination 1
Who Actually Needs Testing
Most immunocompetent adults do NOT need post-vaccination testing. 1, 2 The ACIP recommends anti-HBs testing only for specific high-risk groups:
- Healthcare personnel and public safety workers with potential blood or body fluid exposure 1, 2
- Current or anticipated hemodialysis patients 1, 2
- Immunocompromised individuals: HIV-positive persons, stem-cell transplant recipients, chemotherapy patients 1, 2
- Sexual partners of HBsAg-positive persons 1, 2
Understanding the Results
If anti-HBs ≥10 mIU/mL:
- The person is immune and protected 1
- No further testing or boosters needed for immunocompetent individuals, even if levels decline years later 1, 2
- Long-term protection persists through immunologic memory for decades 1, 2, 3
If anti-HBs <10 mIU/mL:
- Administer one additional vaccine dose and retest 1–2 months later 1
- If still <10 mIU/mL, give a complete second 3-dose series on the appropriate schedule 1
- Retest anti-HBs 1–2 months after the final dose of the second series 1
- If anti-HBs remains <10 mIU/mL after the second series, test for HBsAg to exclude chronic infection 1
- If HBsAg-negative, the person is a non-responder (occurs in 5–10% of vaccinees) and needs counseling about hepatitis B precautions and HBIG prophylaxis after known exposures 1, 2
Critical Pitfalls to Avoid
- Do not order anti-HBc (core antibody) to check vaccine immunity—this marker only appears after natural infection, never from vaccination 2
- A negative anti-HBc in a vaccinated person is expected and reassuring, not concerning 2
- Do not confuse declining antibody titers with loss of protection—immunocompetent individuals retain protection through memory B-cells even when anti-HBs falls below 10 mIU/mL years later 1, 2, 3
- Routine testing years after vaccination in healthy adults is unnecessary and leads to unwarranted revaccination 2
- Different commercial assays may use varying cutoff values; consult the specific test's package insert for accurate interpretation 1
Special Populations Requiring Ongoing Monitoring
- Hemodialysis patients: Annual anti-HBs testing; give booster when levels decline to <10 mIU/mL 1
- Other immunocompromised persons: Consider annual anti-HBs testing and boosters for those with ongoing exposure risk 1
- Infants born to HBsAg-positive mothers: Test at 9–12 months (or 1–2 months after final dose) with both HBsAg and anti-HBs 1, 4